Home/NeoPhore/Michael Shih

MS

Michael Shih

Chief Executive Officer

Therapeutic Areas

NeoPhore Pipeline

Drug	Indication	Phase
MMR Inhibitor Program	MMR-Proficient Solid Tumors (e.g., Colorectal, Endometrial, Gastric Cancers)	Pre-clinical

Leadership Team at NeoPhore

Professor Alberto Bardelli

Scientific Co-Founder

Associate Professor Giovanni Germano

Scientific Co-Founder

View full NeoPhore profile